Augtyro Capsule
Product Images NDC 0003-4040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Augtyro (NDC 0003-4040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by E.r. Squibb & Sons, L.l.c., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Repo-40mg-120ct-btl-lbl (Repo 40mg 120ct Btl Lbl)

Repo-40mg-120ct-btl-lbl (Repo 40mg 120ct Btl Lbl)
Label for Augtyro capsules containing 40 mg of repotrectinib. The label indicates it contains 120 capsules, with directions to swallow whole and is for prescription use only (Rx only). The product is labeled by Bristol Myers Squibb and distributed by E.R. Squibb & Sons, L.L.C. Additional storage and safety information appear on the label.*
FDA Label Image

Repo-40mg-60ct-btl-lbl (Repo 40mg 60ct Btl Lbl)

Repo-40mg-60ct-btl-lbl (Repo 40mg 60ct Btl Lbl)
Label for Augtyro repotrectinib capsules, 40 mg strength. The oral capsule packaging indicates 60 capsules with dosing and storage information printed. Labeler is E.R. Squibb & Sons, L.L.C., part of Bristol Myers Squibb. The label includes a barcode and a warning to keep out of reach of children.*
FDA Label Image

Repo-40mg-60ct-car (Repo 40mg 60ct Car)

Repo-40mg-60ct-car (Repo 40mg 60ct Car)
Box packaging label for Augtyro 40 mg capsules containing repotrectinib. The label shows that the capsules are for oral use and prescription only, distributed by Bristol-Myers Squibb Company. The label includes storage instructions and a reminder to swallow capsules whole. The package size indicated is 60 capsules.*
FDA Label Image

Repo-chem-structure (Repo Chem Structure)

Repo-chem-structure (Repo Chem Structure)
Chemical structure diagram of repotrectinib, the active ingredient in Augtyro capsules. The diagram shows the molecular framework with labeled stereochemistry (R and S configurations) and functional groups including fluorine and methyl substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.